About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,039 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,039 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2281-2300 of 4,039 trials

Active not recruitingHugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)The purpose of this research is to evaluate the safety and performance of the investigational Medtronic Hugo™ Robotic Assisted Surgery (RAS) system when used during hysterectomy…NCT07120945·Jacksonville, Florida and 4 others CompletedLapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or CarboplatinRATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00436644·Scottsdale, Arizona and 2 others TerminatedEngineered Immune Effectors Against Ovarian CancerThis is a single-arm, open-label, phase I/II trial to evaluate the safety and efficacy of ovarian cancer specific cytotoxic lymphocytes (OC-CTLs) in women.NCT03362606·Shenzhen, Guangdong CompletedIxabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00030706·The Bronx, New York

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

UnknownQuestionnaire Study for Gynecological Cancer SurvivorsThe purpose of this study is to evaluate the quality of life of long-term gynecologic cancer survivors.NCT00391664·Washington D.C., District of Columbia and 1 other

WithdrawnProlonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian CancerThe investigators propose to totally abolish the emesis (vomiting) associated with the regimen of oxaliplatin + topotecan by adding a daily administration of aprepitant (Emend)…NCT01017809·New York, New York

RecruitingAbemaciclib for the Treatment of Recurrent Ovarian or Endometrial CancerThis phase II trial studies how well abemaciclib works in treating patients with ovarian or endometrial cancer that has an activation of the CDK4/6 pathway and that has come back…NCT04469764·Los Angeles, California

CompletedVeliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA StatusThe purpose of this study is to investigate the effect of combined topotecan and veliparib (ABT888) treatment in relapsed ovarian cancer with tumor progression and negative or…NCT01690598·Vejle

WithdrawnMOLecular Characterization and Treatment of THYroid Carcinoma on Struma OvariiThyroid carcinoma on struma ovarii (TCSO) is a rare ovarian tumor, derivate from monodermic teratomas.NCT04053114·Bordeaux, Aquitaine

UnknownEarly Detection of Cancers in Low Resource CountriesThe purpose of this study is to implement a community-based combined program for early detection of breast, cervical, ovarian and endometrial cancer in low-resource countries…NCT01178736·São Paulo and 2 others

Active not recruitingA Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor MalignanciesTransCon IL-2 β/γ is an investigational drug being developed for treatment of locally advanced or metastatic solid tumors.NCT05081609·Los Angeles, California and 67 others

Active not recruiting68Ga-FAPI PET/CT in the Staging of High-Grade Epithelial Ovarian Cancers: A Pilot StudyThe investigator will use a technology called PET-CT that combines a Positron Emission Tomography (PET) scan with a computed tomography (CT) scan.NCT05956093·Toronto, Ontario

UnknownStatus of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)Background: The study aims to address the challenge of accurately identifying patients with ovarian cancer who would benefit from poly-ADP ribose inhibitors (PARPi) as first-line…NCT06377267·Barcelona

TerminatedThe Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer SurvivorsMany individuals with ovarian cancer experience distress, fatigue, weakness, anxiety, and other symptoms that decrease quality of life.NCT03641287·Seattle, Washington

RecruitingRetrospective Evaluation of Minimally-Invasive Surgical Strategies in Ovarian Neoplasms (REMISSION Study)This observational study aims to evaluate the outcomes of patients with early-stage epithelial ovarian cancer who are treated with minimally invasive surgery (such as laparoscopic…NCT06879730·Varese, Varese

CompletedTLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerThis phase I trial is studying the side effects and best dose of TLR8 agonist VTX-2337 and pegylated liposomal doxorubicin hydrochloride in treating patients with recurrent or…NCT01294293·Phoenix, Arizona and 9 others

TerminatedIntraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian CancerThe purpose of this study is to determine whether intraperitoneal (IP) Cisplatin combined with intravenous (IV) Paclitaxel is well tolerated in women with epithelial ovarian…NCT00889733·Toronto, Ontario

CompletedDose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian CancerThis is an open-label Phase 1b dose-escalation study to assess the safety, tolerability, and PK of OMP-54F28 when combined with paclitaxel and carboplatin.NCT02092363·New York, New York and 3 others

Not yet recruitingA Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)Researchers are looking for new ways to treat advanced, high-grade ovarian cancer (OC).NCT07743164·Tel Aviv

CompletedInteractive Educational Website for Women With Ovarian Cancer & CaregiversOvarian cancer accounts for more deaths than any other gynecologic malignancy. The majority of patients are diagnosed with Stage III-IV disease.NCT01626014·Minneapolis, Minnesota

PreviousPage 115 of 202Next